Table 4 Baseline Cardiovascular Medications
Control group n = 66 | RIPC group n = 66 | P-value | |
|---|---|---|---|
ß-blocker n (%) | 42 (62.12) | 44 (66.67) | 0.72 |
Calcium channel blocker n (%) | 14 (21.21) | 12 (18.19) | 0.66 |
Angiotensin-converting enzyme inhibitor n (%) | 16 (24.24) | 11 (16.67) | 0.73 |
Angiotensin II receptor blocker n (%) | 35 (53.03) | 33 (50) | 0.28 |
Loop diuretics n (%) | 35 (53.03) | 38 (57.57) | 0.6 |
Thiazide diuretics n (%) | 11 (16.67) | 9 (13.6) | 0.63 |
Spironolacton n (%) | 5 (7.57) | 7 (10.6) | 0.55 |